|
5.3.2009 |
EN |
Official Journal of the European Union |
C 52/11 |
Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the first half of 2008
(2009/C 52/05)
Subcommittee I — On the free movement of goods
To be noted by the EEA Joint Committee
With reference to EEA Joint Committee Decision No 74/1999 of 28 May 1999, the EEA Joint Committee is invited to note the following lists concerning marketing authorisations for medicinal products for the period 1 January-30 June 2008, at their meeting on 7 November 2008:
|
Annex I |
List of new marketing authorisations |
|
Annex II |
List of renewed marketing authorisations |
|
Annex III |
List of extended marketing authorisations |
|
Annex IV |
List of withdrawn marketing authorisations |
ANNEX I
List of new marketing authorisations
The following marketing authorisations have been granted in the EEA EFTA States during the period 1 January-30 June 2008:
|
EU-Number |
Product |
Country |
Date of authorisation |
|
EU/1/05/312/001 |
Xyrem |
Liechtenstein |
30.6.2008 |
|
EU/1/06/334/001-004 |
Evoltra |
Liechtenstein |
30.6.2008 |
|
EU/1/06/370/001-024 |
Exforge |
Liechtenstein |
30.6.2008 |
|
EU/1/06/371/001-024 |
Dafiro |
Liechtenstein |
30.6.2008 |
|
EU/1/06/372/001-024 |
Copalia |
Liechtenstein |
30.6.2008 |
|
EU/1/06/373/001-024 |
Imprida |
Liechtenstein |
30.6.2008 |
|
EU/1/07/001-019/IS |
Retacrit |
Iceland |
16.1.2008 |
|
EU/1/07/393/001 |
Soliris |
Liechtenstein |
30.6.2008 |
|
EU/1/07/400/001-016 |
Mircera |
Liechtenstein |
30.6.2008 |
|
EU/1/07/402/001/NO |
Increlex |
Norway |
31.1.2008 |
|
EU/1/07/421/001-009/IS |
Pioglitazone |
Iceland |
9.1.2008 |
|
EU/1/07/422/001/NO-004/NO |
Tasigna |
Norway |
17.1.2008 |
|
EU/1/07/422/001-004 |
Tasigna |
Liechtenstein |
30.6.2008 |
|
EU/1/07/423/001/NO-003/NO |
Vectibix |
Norway |
21.1.2008 |
|
EU/1/07/423/001-003 |
Vectibix |
Liechtenstein |
30.6.2008 |
|
EU/1/07/423/001-003/IS |
Vectibix |
Iceland |
28.1.2008 |
|
EU/1/07/427/001/NO-037/NO |
Olanzapine Teva |
Norway |
7.1.2008 |
|
EU/1/07/427/001-047/IS |
Olanzapine Teva |
Iceland |
7.1.2008 |
|
EU/1/07/428/001 |
Abraxane |
Liechtenstein |
29.2.2008 |
|
EU/1/07/428/001/IS |
Abraxane |
Iceland |
24.1.2008 |
|
EU/1/07/428/001/NO |
Abraxane |
Norway |
21.1.2008 |
|
EU/1/07/430/001 |
Atripla |
Liechtenstein |
30.6.2008 |
|
EU/1/07/430/001/IS |
Atripla |
Iceland |
28.1.2008 |
|
EU/1/07/430/001/NO |
Atripla |
Norway |
29.1.2008 |
|
EU/1/07/431/001/NO-019/NO |
Retacrit |
Norway |
17.1.2008 |
|
EU/1/07/431/001-019 |
Retacrit |
Liechtenstein |
30.6.2008 |
|
EU/1/07/432/001/NO-019/NO |
Silapo |
Norway |
17.1.2008 |
|
EU/1/07/432/001-019 |
Silapo |
Liechtenstein |
29.2.2008 |
|
EU/1/07/432/001-019/IS |
Silapo |
Iceland |
16.1.2008 |
|
EU/1/07/433/001/IS |
Nevanac |
Iceland |
8.1.2008 |
|
EU/1/07/434/001/NO-003/NO |
Avamys |
Norway |
23.1.2008 |
|
EU/1/07/434/001-003 |
Avamys |
Liechtenstein |
29.2.2008 |
|
EU/1/07/434/001-003/IS |
Avamys |
Iceland |
25.1.2008 |
|
EU/1/07/435/001/NO-018/NO |
Tesavel |
Norway |
24.1.2008 |
|
EU/1/07/435/001-018 |
Tesavel |
Liechtenstein |
30.4.2008 |
|
EU/1/07/435/001-018/IS |
Tesavel |
Iceland |
24.1.2008 |
|
EU/1/07/436/001/NO-002/NO |
Isentress |
Norway |
16.1.2008 |
|
EU/1/07/436/001-002 |
Isentress |
Liechtenstein |
29.2.2008 |
|
EU/1/07/436/001-002/IS |
Isentress |
Iceland |
18.1.2008 |
|
EU/1/07/437/001/NO-002/NO |
Ivemend |
Norway |
31.1.2008 |
|
EU/1/07/437/001-002 |
Ivemend |
Liechtenstein |
29.2.2008 |
|
EU/1/07/437/001-002/IS |
Ivemend |
Iceland |
22.1.2008 |
|
EU/1/07/438/001/NO-004/NO |
Myfenac |
Norway |
14.3.2008 |
|
EU/1/07/438/001-004 |
Myfenax |
Liechtenstein |
30.4.2008 |
|
EU/1/07/438/001-004/IS |
Myfenax |
Iceland |
17.3.2008 |
|
EU/1/07/439/001/NO-004/NO |
Mycophenolate mofetil Teva |
Norway |
14.3.2008 |
|
EU/1/07/439/001-004 |
Mycophenolate mofetil Teva |
Liechtenstein |
30.4.2008 |
|
EU/1/07/439/001-004/IS |
Mycophenolate mofetil Teva |
Iceland |
17.3.2008 |
|
EU/1/07/440/001/NO-002/NO |
Tyverb |
Norway |
17.6.2008 |
|
EU/1/07/440/001-002/IS |
Tyverb |
Iceland |
26.6.2008 |
|
EU/1/08/441/001/NO-010/NO |
Effentora |
Norway |
15.4.2008 |
|
EU/1/08/441/001-010 |
Effentora |
Liechtenstein |
30.4.2008 |
|
EU/1/08/441/001-010/IS |
Effentora |
Iceland |
17.4.2008 |
|
EU/1/08/442/001/NO-008/NO |
Pradaxa |
Norway |
14.4.2008 |
|
EU/1/08/442/001-008 |
Pradaxa |
Liechtenstein |
30.4.2008 |
|
EU/1/08/442/001-008/IS |
Pradaxa |
Iceland |
26.3.2008 |
|
EU/1/08/443/001 |
Thalidomide Pharmion |
Liechtenstein |
30.4.2008 |
|
EU/1/08/443/001/IS |
Thalidomide Pharmion |
Iceland |
21.4.2008 |
|
EU/1/08/443/001/NO |
Thalidomide Pharmion |
Norway |
16.5.2008 |
|
EU/1/08/446/001/NO-003/NO |
Privigen |
Norway |
19.5.2008 |
|
EU/1/08/446/001-003 |
Privigen |
Liechtenstein |
30.6.2008 |
|
EU/1/08/446/001-003/IS |
Privigen |
Iceland |
23.5.2008 |
|
EU/1/08/447/001/NO-004/NO |
Adenuric |
Norway |
24.6.2008 |
|
EU/1/08/447/001-004 |
Adenuric |
Liechtenstein |
30.4.2008 |
|
EU/1/08/447/001-004/IS |
Adenuric |
Iceland |
16.5.2008 |
|
EU/1/08/448/001/NO-002/NO |
Mycamine |
Norway |
21.5.2008 |
|
EU/1/08/448/001-002 |
Mycamine |
Liechtenstein |
30.4.2008 |
|
EU/1/08/448/001-002/IS |
Mycamine |
Iceland |
28.5.2008 |
|
EU/1/08/451/001/NO-004/NO |
Volibris |
Norway |
29.4.2008 |
|
EU/1/08/451/001-002/IS |
Volibris |
Iceland |
21.5.2008 |
|
EU/1/08/451/001-004 |
Volibris |
Liechtenstein |
30.4.2008 |
|
EU/1/08/452/001 |
Pandemrix |
Liechtenstein |
30.6.2008 |
|
EU/1/08/452/001/IS |
Pandemrix |
Iceland |
23.5.2008 |
|
EU/1/08/452/001/NO |
Pandemrix |
Norway |
20.5.2008 |
|
EU/1/08/453/001 |
Prepandrix |
Liechtenstein |
30.6.2008 |
|
EU/1/08/453/001/IS |
Prepandrix |
Iceland |
23.5.2008 |
|
EU/1/08/454/001/NO-004/NO |
Extavia |
Norway |
3.6.2008 |
|
EU/1/08/454/001-004 |
Extavia |
Liechtenstein |
30.6.2008 |
|
EU/1/08/454/001-004/IS |
Extavia |
Iceland |
30.5.2008 |
|
EU/2//08/081/001-003 |
Posatex |
Liechtenstein |
30.6.2008 |
|
EU/2/04/044/007/IS |
Aivlosin |
Iceland |
19.6.2008 |
|
EU/2/07/073/001/NO-004/NO |
Nobilis Influenza H7N1 |
Norway |
4.1.2008 |
|
EU/2/07/076/001/NO-004/NO |
Nobilis Influenza H5N6 |
Norway |
13.3.2008 |
|
EU/2/07/076/001-004 |
Nobilis Influenza H5N6 |
Liechtenstein |
29.2.2008 |
|
EU/2/07/077/001/NO-005/NO |
Meloxivet |
Norway |
7.2.2008 |
|
EU/2/07/077/001-004/IS |
Meloxivet |
Iceland |
27.6.2008 |
|
EU/2/07/078/001/NO-003/NO |
Rheumocam |
Norway |
25.2.2008 |
|
EU/2/07/078/001-002/IS |
Rheumocam |
Iceland |
25.1.2008 |
|
EU/2/07/078/001-003 |
Rheumocam |
Liechtenstein |
29.2.2008 |
|
EU/2/07/079/001/NO-004/NO |
Ingelvac CircoFLEX |
Norway |
26.3.2008 |
|
EU/2/07/079/001-004 |
Ingelvac CircoFLEX |
Liechtenstein |
29.2.2008 |
|
EU/2/07/079/001-004/IS |
Ingelvac CircoFLEX |
Iceland |
19.3.2008 |
ANNEX II
List of renewed marketing authorisations
The following marketing authorisations have been renewed in the EEA EFTA States during the period 1 January-30 June 2008:
|
EU-Number |
Product |
Country |
Date of authorisation |
|
EU/1/02/246/001/NO-003/NO |
Carbaglu |
Norway |
30.5.2008 |
|
EU/1/02/246/001-003 |
Carbaglu |
Liechtenstein |
30.6.2008 |
|
EU/1/02/246/001-003/IS |
Carbaglu |
Iceland |
29.5.2008 |
|
EU/1/03/247/001/NO-002/NO |
Forsteo |
Norway |
1.7.2008 |
|
EU/1/03/247/001-002 |
Forsteo |
Liechtenstein |
30.6.2008 |
|
EU/1/03/247/001-002/IS |
Forsteo |
Iceland |
21.5.2008 |
|
EU/1/03/248/001/NO-012/NO |
Levitra |
Norway |
25.2.2008 |
|
EU/1/03/248/001-012/IS |
Levitra |
Iceland |
19.2.2008 |
|
EU/1/03/249/001/NO-012/NO |
Vivanza |
Norway |
25.2.2008 |
|
EU/1/03/249/001-012 |
Vivanza |
Liechtenstein |
29.2.2008 |
|
EU/1/03/249/001-012/IS |
Vivanza |
Iceland |
19.2.2008 |
|
EU/1/03/250/001 |
Ytracis |
Liechtenstein |
29.2.2008 |
|
EU/1/03/250/001/IS |
Ytracis |
Iceland |
28.2.2008 |
|
EU/1/03/250/001/NO |
Ytracis |
Norway |
25.2.2008 |
|
EU/1/03/251/001/NO-002/NO |
Hepsera |
Norway |
4.4.2008 |
|
EU/1/03/251/001-002 |
Hepsera |
Liechtenstein |
30.4.2008 |
|
EU/1/03/251/001-002/IS |
Hepsera |
Iceland |
10.4.2008 |
|
EU/1/03/253/001/NO-003/NO |
Aldurazyme |
Norway |
30.5.2008 |
|
EU/1/03/253/001-003 |
Aldurazyme |
Liechtenstein |
30.6.2008 |
|
EU/1/03/253/001-003/IS |
Aldurazyme |
Iceland |
22.5.2008 |
|
EU/1/06/367/001/NO-012/NO |
Diacomit |
Norway |
7.1.2008 |
|
EU/1/06/367/001-012 |
Diacomit |
Liechtenstein |
29.2.2008 |
|
EU/1/06/367/001-012/IS |
Diacomit |
Iceland |
7.1.2008 |
|
EU/1/06/380/001 |
Prezista |
Liechtenstein |
29.2.2008 |
|
EU/1/06/380/001/IS |
Prezista |
Iceland |
22.1.2008 |
|
EU/1/06/380/001/NO |
Prezista |
Norway |
21.1.2008 |
|
EU/1/97/045/001-004 |
Helicobacter Test INFAI |
Liechtenstein |
30.4.2008 |
|
EU/1/97/045/001-004/IS |
Helicobacter Test INFAI |
Iceland |
9.4.2008 |
|
EU/1/97/054/001&004-005/IS |
Viracept |
Iceland |
21.1.2008 |
|
EU/1/97/054/001, 004-005 |
Viracept |
Liechtenstein |
29.2.2008 |
|
EU/1/97/054/001/NO, 004/NO-005/NO |
Viracept |
Norway |
17.1.2008 |
|
EU/1/97/055/001/NO-003/NO |
Viramune |
Norway |
21.1.2008 |
|
EU/1/97/055/001-003 |
Viramune |
Liechtenstein |
30.4.2008 |
|
EU/1/97/055/001-003/IS |
Viramune |
Iceland |
22.1.2008 |
|
EU/1/97/057/001/IS |
Quadramet |
Iceland |
7.1.2008 |
|
EU/1/97/057/001/NO |
Quadramet |
Norway |
17.1.2008 |
|
EU/1/98/058/001/NO-002/NO |
Combivir |
Norway |
26.2.2008 |
|
EU/1/98/058/001-002 |
Combivir |
Liechtenstein |
29.2.2008 |
|
EU/1/98/058/001-002/IS |
Combivir |
Iceland |
12.3.2008 |
|
EU/1/98/063/001/NO-006/NO |
Rebif |
Norway |
3.6.2008 |
|
EU/1/98/063/001-007 |
Rebif |
Liechtenstein |
30.6.2008 |
|
EU/1/98/063/001-007/IS |
Rebif |
Iceland |
2.6.2008 |
|
EU/1/98/065/001-002 |
Otpison |
Liechtenstein |
30.6.2008 |
|
EU/1/98/066/001/NO-026/NO |
Exelon |
Norway |
3.6.2008 |
|
EU/1/98/066/001-026 |
Exelon |
Liechtenstein |
30.6.2008 |
|
EU/1/98/066/001-026/IS |
Exelon |
Iceland |
29.5.2008 |
|
EU/1/98/067/001/NO-002/NO |
MabThera |
Norway |
24.6.2008 |
|
EU/1/98/067/001-002 |
Mabthera |
Liechtenstein |
30.6.2008 |
|
EU/1/98/067/001-002/IS |
MabThera |
Iceland |
29.5.2008 |
|
EU/1/98/069/001a/NO-007a/NO; EU/1/98/069/001b/NO-007b/NO; EU/1/98/069/008/NO-010/NO |
Plavix |
Norway |
2.7.2008 |
|
EU/1/98/069/001a-001b, 002a-002b, 003a-003b, -004a-004b, 005a-005b, 006a-006b, 007a-007b, 008-010 |
Plavix |
Liechtenstein |
30.6.2008 |
|
EU/1/98/069/001a-007a& 001b-007b&008-010/IS |
Plavix |
Iceland |
27.6.2008 |
|
EU/1/98/070/001a/NO-007a/NO; EU/1/98/070/001b/NO-007b/NO; EU/1/98/070/008/NO-010/NO |
Iscover |
Norway |
2.7.2008 |
|
EU/1/98/070/001a-001b, 002a-002b, 003a-003b, -004a-004b, 005a-005b, 006a-006b, 007a-007b, 008-010 |
Iscover |
Liechtenstein |
30.6.2008 |
|
EU/1/98/070/001a-007a& 001b-007b&008-010/IS |
Iscover |
Iceland |
27.6.2008 |
|
EU/1/98/071/001-006 |
Xenical |
Liechtenstein |
30.6.2008 |
|
EU/1/98/092/001/NO-023/NO |
Prometax |
Norway |
3.6.2008 |
|
EU/1/98/092/001-026 |
Prometax |
Liechtenstein |
30.6.2008 |
|
EU/1/98/092/001-026/IS |
Prometax |
Iceland |
16.6.2008 |
|
EU/2/02/032/001/NO |
Vaxxitek HVT + IBD |
Norway |
24.1.2008 |
|
EU/2/02/033/001/NO |
Dexdomitor |
Norway |
21.1.2008 |
|
EU/2/02/034/001/NO |
Nobivac Bb for cats |
Norway |
24.1.2008 |
|
EU/2/02/035/001/NO-007/NO |
SevoFlo |
Norway |
17.1.2008 |
|
EU/2/02/036/001/NO-002/NO |
Nobilis OR inac |
Norway |
26.2.2008 |
|
EU/2/02/036/001-002 |
Nobilis OR inac |
Liechtenstein |
30.4.2008 |
|
EU/2/02/036/001-002/IS |
Nobilis OR inac |
Iceland |
21.1.2008 |
|
EU/2/03/037/005 |
ProteqFlu |
Liechtenstein |
29.2.2008 |
|
EU/2/03/037/005/IS |
ProteqFlu |
Iceland |
21.1.2008 |
|
EU/2/03/037/005/NO |
ProteqFlu |
Norway |
27.3.2008 |
|
EU/2/03/038/005 |
ProteqFlu-Te |
Liechtenstein |
29.2.2008 |
|
EU/2/03/038/005/IS |
ProteqFlu-Te |
Iceland |
21.1.2008 |
|
EU/2/03/038/005/NO |
ProteqFlu Te |
Norway |
27.3.2008 |
|
EU/2/03/039/001/NO-030/NO |
Advocate |
Norway |
22.4.2008 |
|
EU/2/03/039/001-004&013-14&019-022/IS |
Advocate for cats |
Iceland |
13.3.2008 |
|
EU/2/03/039/001-030 |
Advocate |
Liechtenstein |
29.2.2008 |
|
EU/2/03/039/005-012&015-018&023-030/IS |
Advocate for dogs |
Iceland |
13.3.2008 |
|
EU/2/03/040/001-002 |
Gonazon |
Liechtenstein |
30.6.2008 |
|
EU/2/96/002/001/NO-003/NO |
Fevaxyn Pentofel |
Norway |
12.2.2008 |
|
EU/2/97/001-018/IS |
Dicural |
Iceland |
21.1.2008 |
|
EU/2/97/003/001/NO-018/NO |
Dicural |
Norway |
25.2.2008 |
|
EU/2/97/003/001-018 |
Dicural |
Liechtenstein |
29.2.2008 |
|
EU/2/97/004/001&010/IS |
Metacam for cattle and pigs |
Iceland |
4.1.2008 |
|
EU/2/97/004/003-005&012-013&016-025&029/IS |
Metacam for dogs |
Iceland |
4.1.2008 |
|
EU/2/97/004/006&011/IS |
Metacam for dogs and cats |
Iceland |
4.1.2008 |
|
EU/2/97/004/007-008&014-015&027-028&031-032/IS |
Metacam for cattle, pigs and horses |
Iceland |
4.1.2008 |
|
EU/2/97/004/009&030/IS |
Metacam for horses |
Iceland |
4.1.2008 |
|
EU/2/97/004/026/IS |
Metcam for cats |
Iceland |
4.1.2008 |
|
EU/2/98/006/001-010 |
Nobilis IB 4-91 |
Liechtenstein |
30.6.2008 |
|
EU/2/98/006/001-010/IS |
Nobilis IB 4-91 |
Iceland |
23.5.2008 |
|
EU/2/98/007/001/NO-003/NO |
Clomicalm |
Norway |
26.5.2008 |
|
EU/2/98/007/001-003 |
Clomicalm |
Liechtenstein |
30.4.2008 |
|
EU/2/98/007/001-003/IS |
Clomicalm |
Iceland |
21.4.2008 |
|
EU/2/98/008/001/NO-004/NO |
Neocolipor |
Norway |
21.4.2008 |
|
EU/2/98/008/001-004 |
Neocolipor |
Liechtenstein |
30.4.2008 |
|
EU/2/98/008/001-004/IS |
Neocolipor |
Iceland |
9.4.2008 |
ANNEX III
List of extended marketing authorisations
The following marketing authorisations have been extended in the EEA EFTA States during the period 1 January-30 June 2008:
|
EU-Number |
Product |
Country |
Date of extention |
|
EU/1/00/143/010/NO-011/NO |
Kogenate Bayer |
Norway |
28.1.2008 |
|
EU/1/00/143/010-011 |
Kogenate Bayer |
Liechtenstein |
29.2.2008 |
|
EU/1/00/143/010-011/IS |
Kogenate Bayer |
Iceland |
16.1.2008 |
|
EU/1/00/144/004 |
Helixate NexGen |
Liechtenstein |
29.2.2008 |
|
EU/1/00/144/004/IS |
Helixate NexGen |
Iceland |
16.1.2008 |
|
EU/1/00/144/004/NO |
Helixate NexGen |
Norway |
28.1.2008 |
|
EU/1/00/167/008 |
Prevenar |
Liechtenstein |
30.6.2008 |
|
EU/1/01/172/006 |
Kaletra |
Liechtenstein |
30.4.2008 |
|
EU/1/01/172/006/IS |
Kaletra |
Iceland |
14.4.2008 |
|
EU/1/01/172/006/NO |
Kaletra |
Norway |
14.4.2008 |
|
EU/1/01/195/016/NO-021/NO |
Liprolog |
Norway |
29.1.2008 |
|
EU/1/01/195/016-021 |
Liprolog |
Liechtenstein |
29.2.2008 |
|
EU/1/01/200/002 |
Viread |
Liechtenstein |
30.4.2008 |
|
EU/1/01/200/002/NO |
Viread |
Norway |
23.4.2008 |
|
EU/1/02/213/017-023 |
MicardisPlus |
Liechtenstein |
30.4.2008 |
|
EU/1/02/213/017/NO-023/NO |
MicardisPlus |
Norway |
27.5.2008 |
|
EU/1/02/213/017-023/IS |
MicardisPlus |
Iceland |
15.4.2008 |
|
EU/1/02/214/011-015 |
Kinzalcomb |
Liechtenstein |
30.4.2008 |
|
EU/1/02/215/015-021 |
Pritor Plus |
Liechtenstein |
30.4.2008 |
|
EU/1/02/218/012-029 |
Axura |
Liechtenstein |
30.6.2008 |
|
EU/1/02/218/012-029/IS |
Axura |
Iceland |
28.5.2008 |
|
EU/1/02/218/016/NO-023/NO |
Axura |
Norway |
27.5.2008 |
|
EU/1/02/219/016-021 |
Ebixa |
Liechtenstein |
30.4.2008 |
|
EU/1/02/219/022/NO-049/NO |
Ebixa |
Norway |
21.5.2008 |
|
EU/1/02/219/022-049 |
Ebixa |
Liechtenstein |
30.6.2008 |
|
EU/1/02/219/022-049/IS |
Ebixa |
Iceland |
27.5.2008 |
|
EU/1/03/260/019/NO-023/NO |
Stalevo |
Norway |
27.5.2008 |
|
EU/1/03/260/019-023 |
Stalevo |
Liechtenstein |
30.4.2008 |
|
EU/1/03/260/019-023/IS |
Stalevo |
Iceland |
20.5.2008 |
|
EU/1/03/267/008/NO-009/NO |
Reyataz |
Norway |
16.5.2008 |
|
EU/1/03/267/008-009 |
Reyataz |
Liechtenstein |
30.4.2008 |
|
EU/1/03/267/008-009/IS |
Reyataz |
Iceland |
22.4.2008 |
|
EU/1/03/268/004 |
Cholestagel |
Liechtenstein |
30.6.2008 |
|
EU/1/03/271/001-006/IS |
Advate |
Iceland |
30.5.2008 |
|
EU/1/03/271/005/NO-006/NO |
Advate |
Norway |
3.6.2008 |
|
EU/1/03/271/005-006 |
Advate |
Liechtenstein |
30.6.2008 |
|
EU/1/04/274/002 |
Velcade |
Liechtenstein |
30.4.2008 |
|
EU/1/04/274/002/NO |
Velcade |
Norway |
21.4.2008 |
|
EU/1/04/279/036-043 |
Lyrica |
Liechtenstein |
29.2.2008 |
|
EU/1/04/283/008/NO-012/NO |
Ariclaim |
Norway |
17.1.2008 |
|
EU/1/04/283/008-012/IS |
Ariclaim |
Iceland |
15.2.2008 |
|
EU/1/04/298/003 |
Kivexa |
Liechtenstein |
30.4.2008 |
|
EU/1/04/298/003/NO |
Kivexa |
Norway |
29.2.2008 |
|
EU/1/06/357/018-021 |
Gardasil |
Liechtenstein |
30.4.2008 |
|
EU/1/06/358/018-021 |
Silgard |
Liechtenstein |
30.4.2008 |
|
EU/1/06/366/017/NO-022/NO |
Tandemact |
Norway |
22.4.2008 |
|
EU/1/06/366/017-022 |
Tandemact |
Liechtenstein |
30.4.2008 |
|
EU/1/06/366/017-022/IS |
Tandemact |
Iceland |
16.4.2008 |
|
EU/1/06/368/058-087 |
Insulin Human Winthrop |
Liechtenstein |
29.2.2008 |
|
EU/1/06/370/025-033 |
Exforge |
Liechtenstein |
30.6.2008 |
|
EU/1/06/371/025-033 |
Dafiro |
Liechtenstein |
30.6.2008 |
|
EU/1/06/372/025-033 |
Copalia |
Liechtenstein |
30.6.2008 |
|
EU/1/06/373/025-033 |
Imprida |
Liechtenstein |
30.6.2008 |
|
EU/1/07/387/009/NO-010/NO |
Advagraf |
Norway |
25.1.2008 |
|
EU/1/07/387/009-010 |
Advagraf |
Liechtenstein |
29.2.2008 |
|
EU/1/07/388/002 |
Sebivo |
Liechtenstein |
29.2.2008 |
|
EU/1/07/388/002/NO |
Sebivo |
Norway |
28.2.2008 |
|
EU/1/96/006/004/NO-006/NO |
NovoSeven |
Norway |
21.5.2008 |
|
EU/1/96/006/004-006 |
NovoSeven |
Liechtenstein |
30.4.2008 |
|
EU/1/96/006/004-006/IS |
NovoSeven |
Iceland |
22.5.2008 |
|
EU/1/96/007/031/NO-038/NO |
Humalog |
Norway |
31.1.2008 |
|
EU/1/96/007/031-038 |
Humalog |
Liechtenstein |
29.2.2008 |
|
EU/1/96/027/006/NO-007/NO |
Hycamtin |
Norway |
9.4.2008 |
|
EU/1/96/027/006-007 |
Hycamtin |
Liechtenstein |
30.4.2008 |
|
EU/1/96/027/006-007/IS |
Hycamtin |
Iceland |
26.3.2008 |
|
EU/1/97/030/085-139 |
Insuman |
Liechtenstein |
29.2.2008 |
|
EU/1/98/069/008/NO-010/NO |
Plavix |
Norway |
22.4.2008 |
|
EU/1/98/069/008-010 |
Plavix |
Liechtenstein |
30.4.2008 |
|
EU/1/98/069/008-010/IS |
Plavix |
Iceland |
17.4.2008 |
|
EU/1/98/070/008/NO-010/NO |
Iscover |
Norway |
19.5.2008 |
|
EU/1/98/070/008-010 |
Iscover |
Liechtenstein |
30.4.2008 |
|
EU/1/98/070/008-010/IS |
Iscover |
Iceland |
17.4.2008 |
|
EU/1/99/119/015 |
NovoRapid |
Liechtenstein |
30.4.2008 |
|
EU/1/99/119/015/NO |
NovoRapid |
Norway |
25.2.2008 |
|
EU/2/04/044/007 |
Aivlosin |
Liechtenstein |
30.6.2008 |
|
EU/2/04/045/007/NO |
Previcox |
Norway |
29.1.2008 |
|
EU/2/97/004/031-032 |
Metacam |
Liechtenstein |
30.6.2008 |
ANNEX IV
List of withdrawn marketing authorisations
The following marketing authorisations have been withdrawn in the EEA EFTA States during the period 1 January-30 June 2008:
|
EU-Number |
Product |
Country |
Date of withdrawal |
|
EU/1/01/192/001/NO-005/NO |
Levviax |
Norway |
24.1.2008 |
|
EU/1/02/207/001-020 |
Quixidar |
Liechtenstein |
30.4.2008 |
|
EU/1/02/207/001-020/IS |
Quixidar |
Iceland |
11.3.2008 |
|
EU/1/02/207/001-020/NO |
Quixidar |
Norway |
2.4.2008 |
|
EU/1/99/098/001-002 |
Zenapax |
Liechtenstein |
30.6.2008 |
|
EU/2/00/025/001-004 |
Advasure |
Liechtenstein |
30.6.2008 |